| more general categories |
information about this item |
|
| 03. Biological Effects of Specific Chemicals |
 |
 |
|
03. Biological Effects of Specific Chemicals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
alogliptin benzoate [CHEBI:72324] (1) |
|
 |
| 05. Industrial Uses |
 |
 |
|
05. Industrial Uses |
|
|
|
|
|
|
|
|
|
|
|
alogliptin benzoate [CHEBI:72324] (1) |
|
 |
| 08. Chemical Category |
 |
 |
|
08. Chemical Category |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
alogliptin benzoate [CHEBI:72324] (1) |
|
 |
| ChEBI Compound Accession Identifier: |
[CHEBI:72324] |
| ChEBI Compound Description: |
A benzoate salt obtained by combining equimolar amounts of alogliptin and benzoic acid. Used for treatment of type 2 diabetes. |
| ChEBI Compound Identification Number: |
72324 |
| ChEBI InChI Value: |
"InChI=1S/C18H21N5O2.C7H6O2/c1-21-17(24)9-16(22-8-4-7-15(20)12-22)23(18(21)25)11-14-6-3-2-5-13(14)10-19;8-7(9)6-4-2-1-3-5-6/h2-3,5-6,9,15H,4,7-8,11-12,20H2,1H3;1-5H,(H,8,9)/t15-;/m1./s1" |
| ChEBI InChIKey Value: |
KEJICOXJTRHYAK-XFULWGLBSA-N |
| ChEBI Compound Name: |
alogliptin benzoate |
| ChEBI SMILES Value: |
OC(=O)c1ccccc1.Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O |
| ChEBI Substance ID: |
160962874 |
| ChEBI URL: |
ChEBI:72324 |
| ChemSpider ID: |
17246652 |
| Ontomatica Chemical Accession Key (OnChAKey): |
KEJICOXJTRHYAK_XFULWGLBSA_N_000_000000 |
| PubChem Compound ID: |
16088021 |